# A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects

> **NCT06991634** · PHASE1 · COMPLETED · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Azvudine tablets

## Key facts

- **NCT ID:** NCT06991634
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-08
- **Primary completion:** 2023-04-27
- **Final completion:** 2023-06-20
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991634, "A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06991634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*